Browse Category

NASDAQ:CFLT News 3 January 2026 - 7 February 2026

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent stock stays pinned below IBM’s $31 bid as vote nears and SEC filing flags lawsuits

Confluent shares traded near $30.36 premarket Friday, just below IBM’s $31-per-share cash offer, after the company filed new merger disclosures with the SEC in response to shareholder demand letters and lawsuits. Confluent will report earnings Feb. 11 but will not hold a call or forecast while the IBM deal remains pending. The shareholder vote is set for Feb. 12.
Confluent stock (CFLT) sits under IBM’s $31 bid after fresh merger filing flags shareholder lawsuits

Confluent stock (CFLT) sits under IBM’s $31 bid after fresh merger filing flags shareholder lawsuits

Confluent shares traded at $30.36 after hours Thursday, just below IBM’s $31-per-share cash offer. The company filed additional merger disclosures following 17 shareholder demand letters and two lawsuits alleging proxy omissions. A shareholder vote on the IBM acquisition is set for Feb. 12. The stock’s narrow spread reflects market focus on deal completion risk.
Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote

Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote

Confluent shares edged up 0.1% to $30.37 Thursday after the company disclosed new details on shareholder litigation tied to its pending $11 billion IBM acquisition. The stock traded about 2% below IBM’s $31-per-share offer as investors watched for the Feb. 12 shareholder vote and Confluent’s earnings report on Feb. 11.
IBM stock slides again as AI disruption fears grip software; Confluent vote nears

IBM stock slides again as AI disruption fears grip software; Confluent vote nears

IBM shares fell 1.8% to $289.05 Wednesday, extending an 8% slide since Monday amid a global software selloff tied to AI disruption fears. Confluent, which IBM plans to acquire, disclosed lawsuits and shareholder demands over its merger proxy, but said it will issue supplemental disclosures. IBM declared a $1.68 per share dividend, payable March 10. Confluent shareholders will vote on the deal February 12.
Confluent stock price today: CFLT stays just under IBM’s $31 offer as February deadlines near

Confluent stock price today: CFLT stays just under IBM’s $31 offer as February deadlines near

Confluent shares traded at $30.42 Wednesday, about 2% below IBM’s $31-per-share cash offer, as investors await a February 12 shareholder vote on the $11 billion deal. The U.S. antitrust waiting period expired January 12, but the merger still needs shareholder and further regulatory approval. Confluent will report earnings February 11 without a call or outlook. Trading volume surged to 53 million shares ahead of key dates.
Confluent stock hovers below IBM’s $31 bid as key vote, results near

Confluent stock hovers below IBM’s $31 bid as key vote, results near

Confluent shares closed at $30.34 on Wednesday, about 2% below IBM’s $31-per-share cash offer, as software stocks fell and IBM dropped 4%. Heavy trading volume followed ahead of Confluent’s earnings report on Feb. 11 and a shareholder vote on Feb. 12. The spread to IBM’s bid now signals deal risk and timing. U.S. antitrust review ended Jan. 12, but other approvals remain pending.
IBM stock drops 3% as Confluent deal clears key U.S. antitrust step ahead of Jan. 28 earnings

IBM stock drops 3% as Confluent deal clears key U.S. antitrust step ahead of Jan. 28 earnings

New York, January 13, 2026, 21:08 ET — Markets have shut down for the day. Confluent confirmed that the U.S. antitrust waiting period for International Business Machines’ $11 billion acquisition has lapsed, marking a key regulatory milestone. The Hart-Scott-Rodino Act’s waiting period expired at 11:59 p.m. ET on Jan. 12. IBM shares closed Tuesday down 2.9% at $303.16. Confluent also announced a shareholder meeting scheduled for Feb. 12 but noted that additional regulatory approvals remain pending. The Hart-Scott-Rodino process requires buyers and targets to alert U.S. antitrust regulators and pause before finalizing a deal. Once the waiting period ends, it
Confluent scraps earnings call ahead of IBM takeover — what it means for CFLT stock

Confluent scraps earnings call ahead of IBM takeover — what it means for CFLT stock

NEW YORK, Jan 13, 2026, 02:45 EST Confluent (CFLT.O) said on Monday it will report fourth-quarter and full-year 2025 results on Feb. 11, but it will not hold an earnings conference call or provide a financial outlook because of its pending sale to IBM (IBM.N). https://www.businesswire.com/news/home/20260112152645/en/Confluent-to-Announce-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-on-February-11-2026 That matters now because earnings calls are usually where management answers the only question deal traders keep asking: is anything slowing down. With no call, the stock loses one of its few near-term pressure points. The absence of guidance also keeps the focus on timing and odds, not the quarter itself. For a cash
Confluent stock drifts after New Year’s open — the IBM deal deadline traders are watching

Confluent stock drifts after New Year’s open — the IBM deal deadline traders are watching

NEW YORK, Jan 3, 2026, 15:58 ET — Market closed Confluent shares slipped 0.4% to $30.11 at Friday’s close, after trading between $30.09 and $30.30. Volume was about 29.4 million shares. The stock’s day-to-day move matters now mostly for takeover math, not fundamentals. Confluent is in a pending all-cash acquisition, and traders are watching how tightly the shares track the deal price. The broader market backdrop can still shift that spread. U.S. stocks opened 2026 with choppy trading as Treasury yields climbed, a mix that tends to pressure growth names and raise the return investors demand for waiting on cash
1 2 3 4

Stock Market Today

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
New York, Feb 7, 2026, 05:42 EST — Market closed. PepsiCo (PEP.O) has priced a €2.5 billion ($2.7 billion) four-part euro bond deal, tapping Europe’s debt market days after it laid out new affordability moves in its core snacks aisle. (Source: SEC filing). The funding matters now because investors have been fixated on whether big consumer brands can protect volumes after years of price rises. For PepsiCo, the bond sale also lines up fresh money to refinance short-term borrowings while it tries to steady demand in North America. PepsiCo shares ended Friday at $170.49, up 1.77%, after a broad U.S.
Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Go toTop